Hannah Brendan

CIK 00019294221 companySOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001929422

Recent Transactions

23 trades

Exercise/Conversion
Quince Therapeutics, Inc.$QNCX
Employee Stock Option (Right to Buy)
2025-12-05−25,280→ 199,720 total
Exercise/Conversion
Quince Therapeutics, Inc.$QNCX
Common Shares
2025-12-05$0.94/sh+25,280→ 361,827 total
Exercise/Conversion
Quince Therapeutics, Inc.$QNCX
Common Shares
2025-12-05$0.55/sh+2,271→ 336,547 total
Exercise/Conversion
Quince Therapeutics, Inc.$QNCX
Employee Stock Option (Right to Buy)
2025-12-05−2,271→ 45,168 total
Award
Quince Therapeutics, Inc.$QNCX
Common Shares
2025-06-18$1.20/sh+37,736→ 334,276 total
Award
Quince Therapeutics, Inc.$QNCX
Warrants
2025-06-18$0.13/sh+37,736→ 37,736 total
Award
Quince Therapeutics, Inc.$QNCX
Employee Stock Option (right to buy)
2025-01-28+450,000→ 450,000 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2024-08-21$0.63/sh+23,565→ 296,540 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2024-08-21$0.61/sh+2,280→ 267,975 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2024-08-21$0.62/sh+5,000→ 272,975 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2024-08-20$0.61/sh+2,500→ 262,271 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2024-08-20$0.60/sh+3,424→ 265,695 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2024-08-19$0.58/sh+2,155→ 259,771 total
Exercise/Conversion
Quince Therapeutics, Inc.$QNCX
Employee Stock Option (right to buy)
2024-06-04−56,061→ 47,439 total
Exercise/Conversion
Quince Therapeutics, Inc.$QNCX
Common Stock
2024-06-04$0.55/sh+56,061→ 257,616 total
Award
Quince Therapeutics, Inc.$QNCX
Employee Stock Option (right to buy)
2024-02-01+600,000→ 600,000 total
Award
Quince Therapeutics, Inc.$QNCX
Employee Stock Option (right to buy)
2023-10-24+75,000→ 75,000 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2023-08-08$1.22/sh+71,762→ 201,555 total
Award
Quince Therapeutics, Inc.$QNCX
Employee Stock Option (right to buy)
2023-02-01+225,000→ 225,000 total
Award
Quince Therapeutics, Inc.$QNCX
Employee Stock Option (right to buy)
2022-05-23+353,656→ 353,656 total
Award
Quince Therapeutics, Inc.$QNCX
Employee Stock Option (right to buy)
2022-05-19+103,500→ 103,500 total
Award
Quince Therapeutics, Inc.$QNCX
Common Stock
2022-05-19+16,224→ 16,224 total
Award
Quince Therapeutics, Inc.$QNCX
Common Stock
2022-05-19+113,569→ 129,793 total

Companies

Quince Therapeutics, Inc.
CBO, COO and CCO
$QNCX

Recent Filings

Address

C/O QUINCE THERAPEUTICS, INC. 611 GATEWAY BLVD, SUITE 273

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov